The complicated connections between weight loss drugs and mental health Mental illness can cause or worsen obesity, and obesity can cause or worsen mental illness
An analysis of the FDA Adverse Event Reporting System (collecting worldwide adverse events) identified an increased reporting odds ratio for alopecia with semaglutide and tirzepatide, while no significant increase was observed for liraglutide, dulaglutide, exenatide, or lixisenatide [81]
Early waistline changes are beginning to emerge, often visible as a tighter appearance around the lower abdomen
That is the right scientific response, but it also illustrates how much foundational dose finding and pharmacodynamic characterization lies ahead
Vila Petroff MG, Egan JM, Wang X, Sollott SJ: Glucagon- like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes